Global Next-Generation Sequencing on Drug Development Market
Report Scope:
The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.
This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.
This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.
BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.
Report Includes:
52 data tables and 39 additional tables
An overview of the global markets for next-generation sequencing on drug development
Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Highlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region
Examination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments
Coverage of recent advances, emerging technologies, and developments of the industry
Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
Profiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.
Companies Mentioned
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI (Beijing Genomics Institute)
BIO-RAD LABORATORIES INC.
CD GENOMICS
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
Micronoma
NEW ENGLAND BIOLABS
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PERKINELMER INC.
PRECISION FOR MEDICINE, FORMERLY APOCELL
PROMEGA CORP.
Psomagen Inc.
QIAGEN
ROCHE HOLDING AG
TAKARA BIO INC.
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Research Methodology
- Information Sources
- Geographic Breakdown
- Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
- Chapter 3 Market Overview
- Introduction
- Technology Background
- Structure and Importance of DNA
- DNA Sequencing Technologies
- Whole Genome Sequencing
- Targeted Resequencing
- ChIP Sequencing
- RNA Sequencing
- Methylation Sequencing
- History of DNA Sequencing
- Sanger Sequencing
- Introduction to Next Generation Sequencing (NGS)
- Advantages of NGS
- Roche 454 Pyrosequencing
- Illumina NGS
- Thermo Fisher Scientific (Life Technologies) NGS
- Sequencing Instruments
- Benchtop Sequencers
- Informatics Technologies
- NGS in Drug Development
- NGS Service Providers
- Chapter 4 Market Dynamics
- Market Drivers
- Increasing R&D Activities using NGS technologies
- Increase in Healthcare Expenditure
- Technological Advancements in Sequencing Platforms
- Shift Towards Precision Medicine
- Growing demand of NGS for Designing Individualized Medicine to Cancer Patients
- High Accuracy and Low Cost
- Market Restraints
- Limitations Associated with NGS Technology
- Other Clinical Sequencing Technology Challenges
- Market Opportunities
- Rising R&D in NGS creates lucrative Opportunities for Manufacturers
- Chapter 5 NGS in Drug Development by Product Type
- Introduction
- Instruments
- Consumables
- Services
- Chapter 6 NGS Market in Drug Development by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Centers
- Other End Users
- Chapter 7 NGS Market in Drug Development by Region
- Market Overview and Discussion
- North America
- Asia-Pacific
- Europe
- Rest of the World
- Chapter 8 Sustainability of NGS in Drug Development: An ESG Perspective
- Introduction to ESG
- Sustainability of NGS in Drug Development: An ESG Perspective
- Key ESG Issues
- Consumer Attitudes Towards ESG
- Industry ESG Performance Analysis
- Case Study
- Environment
- Social
- Governance
- Concluding Remarks from BCC
- Chapter 9 Emerging Technologies and Developments
- Overview
- Emerging Technologies in the Market
- Application of Artificial Intelligence (AI) in NGS
- Single-Molecule Real-Time Sequencing
- Nanopore Technology
- Microscopy-Based Sequencing
- Chapter 10 Patent Analysis
- Introduction
- Patents on NGS by Region
- Chapter 11 M&A and Funding Outlook
- M&A Analysis
- Chapter 12 Competitive Landscape
- Global Company Ranking
- Global Company Ranking for NGS Instruments in Drug Development
- Global Company Ranking for NGS Consumables in Drug Development
- Global Company Ranking for NGS Services in Drug Development
- Chapter 13 Company Profiles
- 10X GENOMICS
- AGILENT TECHNOLOGIES INC.
- BGI (BEIJING GENOMICS INSTITUTE)
- BIO-RAD LABORATORIES INC.
- CD GENOMICS
- ILLUMINA INC.
- INTEGRATED DNA TECHNOLOGIES INC.
- MICRONOMA
- NEW ENGLAND BIOLABS
- OXFORD NANOPORE TECHNOLOGIES
- PACIFIC BIOSCIENCES OF CALIFORNIA INC.
- PERKINELMER INC.
- PROMEGA CORP.
- PSOMAGEN INC.
- PRECISION FOR MEDICINE, FORMERLY APOCELL
- QIAGEN
- ROCHE HOLDING AG
- THERMO FISHER SCIENTIFIC INC.
- TAKARA BIO INC.
- TECAN GROUP LTD.
- Chapter 14 Appendix: Acronyms
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook